Phillip A. Dennis
305 works · 25,540 citations · h-index 58
Top works
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
- Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
- Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
- Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.
- Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells.
- Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors
- Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor.
- Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells
- PTEN loss in the continuum of common cancers, rare syndromes and mouse models
- Activation of the PI3K/Akt pathway and chemotherapeutic resistance
- Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations
- Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
- PTEN hamartoma tumor syndromes
- Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2.
- Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer
- Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC
- Metformin Prevents Tobacco Carcinogen–Induced Lung Tumorigenesis
- Growth factor control of extracellular proteolysis
- Novel PI Analogues Selectively Block Activation of the Pro-survival Serine/Threonine Kinase Akt
- An Overview of Lung Cancer Genomics and Proteomics